QGEN - Spark Newswire

3 minute read

QIAGEN And GT Molecular Collaborate To Offer A Complete SARS-CoV-2 Wastewater Detection Solution Based On QIAcuity Digital PCR Technology

Today, 11:10 PM

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases Collaboration combines QIAcuity digital PCR

QGEN

1 minute read

Qiagen Inks Companion Diagnostic Development, Technology-Licensing Deal With OncXerna

By Vandana Singh

Today, 11:10 PM

Qiagen NV (NYSE:QGEN) and OncXerna Therapeutics have signed a master agreement to develop a next-generation sequencing (NGS) companion diagnostic for navicixizumab, which OncXerna…

QGEN

3 minute read

QIAGEN Reports Licensing, Master Companion Diagnostics Deal With OncXerna, No Terms Disclosed

By Benzinga Newsdesk

Today, 11:10 PM

QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna™ TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab

QGEN

1 minute read

Qiagen’s COVID-19 Antigen Test Gets FDA Emergency Use Approval

By Vandana Singh

Today, 11:10 PM

The FDA has granted emergency use authorization (EUA) to Qiagen N.V.’s (NYSE:QGEN) QIAreach SARS CoV-2 Antigen Test. The rapid, portable test can…

QGEN

1 minute read

FDA
News

Qiagen Receives U.S. FDA Emergency Use Authorization For Rapid Portable Test That Can Analyze Over 30 Samples/Hour For SARS-Cov-2 Antigen

By Michael Horton

Today, 11:10 PM

-Reuters

QGEN

1 minute read

Qiagen Stock Gains As Non COVID Sales Boosts Q2 Topline, Bottom-line

By Vandana Singh

Today, 11:10 PM

Qiagen N.V. (NYSE:QGEN) reported after the close of the market Thursday that its second-quarter revenues jumped 28% Y/Y as growth in…

QGEN

22 minute read

Earnings Scheduled For July 29, 2021

By Benzinga Insights

Today, 11:10 PM

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 11:10 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV

2 minute read

FDA
News

QIAGEN Says Co’s NeuMoDx HAdV Quant Assay Secures CE-IVD Certification For Automated Testing To Detect Human Adenovirus Infections

By Benzinga Newsdesk

Today, 11:10 PM

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced that its NeuMoDx™ HAdV Quant Assay for the identification and quantification of human adenovirus (HAdV) DNA has received CE-IVD

QGEN

3 minute read

Labcorp Launches Companion Diagnostic For Amgen’s Newly-Approved Lung Cancer Therapy

By Benzinga Newsdesk

Today, 11:10 PM

Labcorp® (NYSE:LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with

AMGN

Feed Symbols: QGEN